Cited by 34Vitamin C and Antioxidants ResearchAntioxidant Activity and Oxidative StressPhytochemicals and Antioxidant Activities

Determination of plasma and leukocyte vitamin C concentrations in a randomized, double-blind, placebo-controlled trial with Ester-C(®)

Open access
Mitmesser, Susan H., Ye, Qian, Evans, Mal, Combs, Maile·2016·SpringerPlus

Abstract

BACKGROUND: Rapid uptake of vitamin C into blood and retention in tissues are important indicators of the efficacy of vitamin C supplementation and its immune-supporting role. The objective of this study was to evaluate the bioavailability of vitamin C in plasma (reflective of recent intake) and leukocytes (reflective of tissue stores and influences on immune function) from a novel vitamin C formulation, Ester-C(®). METHODS: The study was a double-blind, placebo-controlled, crossover trial. Thirty-six subjects, 18-60 years of age, were randomized to receive placebo (PL, 0 mg vitamin C), ascorbic acid (AA, 1000 mg vitamin C), and Ester-C(®) (EC, 1000 mg vitamin C). Plasma and leukocyte vitamin C were measured baseline and at 2, 4, 8 and 24 h postdose. RESULTS: The concentration and percent change from baseline in plasma were significantly higher with EC at all time points when compared to PL. No significant differences between EC and AA were observed in plasma concentration. Maximum plasma concentration was higher for EC compared to AA (P = 0.039) and PL (P < 0.001). Plasma area under the curve (AUC0-24h) was higher for EC (P < 0.001) compared to PL. The concentration change from baseline in leukocyte vitamin C was increased with EC at 24 h post-dose (P = 0.036) while no significant within-group changes were observed in AA or PL at any time point. The percent change in leukocyte vitamin C concentration was higher for EC at 8 and 24 h compared to AA (P = 0.028 and P = 0.034, respectively) and PL (P = 0.042 and P = 0.036, respectively). CONCLUSIONS: A single dose of EC resulted in favorable percent change in leukocyte vitamin C concentration compared to AA and PL, indicating EC is retained longer within leukocytes. Trial registration ClinicalTrials.gov Identifier NCT01852903.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40064-016-2605-7

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Significant differences were found across preparations in leukocyte vitamin C concentrations, favoring Calcium ascorbate EC, but no differences were observed in plasma vitamin C levels.

    “Significant differences were found across preparations in leukocyte vitamin C concentrations, favoring Calcium ascorbate EC, but no differences were observed in plasma vitamin C levels [16,27].”

    From Enhanced Vitamin C Delivery: A Systematic Literature Review Assessing the Efficacy and Safety of Alternative Supplement Forms in Healthy Adults (2025) · cites this paper as [16]

    The Results (Leukocyte vitamin C; page not provided) report significantly greater percentage changes with Ester-C than with ascorbic acid and placebo at 8 and 24 hours, but the between-group differences in absolute leukocyte concentration changes were not significant. The Results (Plasma vitamin C; page not provided) report no significant difference between Ester-C and ascorbic acid at individual time points; the paper also reports a higher plasma maximum concentration with Ester-C, so the unqualified claim of no plasma differences overstates the finding. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Vitamin C metabolites can enhance leukocyte vitamin C retention without altering plasma levels.

    “A significant finding from these studies is that vitamin C metabolites can enhance leukocyte vitamin C retention without altering plasma levels [16,27].”

    From Enhanced Vitamin C Delivery: A Systematic Literature Review Assessing the Efficacy and Safety of Alternative Supplement Forms in Healthy Adults (2025) · cites this paper as [16]

    The Results and Discussion (page not specified) report greater leukocyte vitamin C retention after Ester-C than after ascorbic acid. They do not support an unqualified claim that plasma levels were unaltered: plasma vitamin C rose with both treatments, and peak plasma concentration was higher with Ester-C, although the overall plasma change did not differ significantly between them. The trial tested Ester-C, not its metabolites separately. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Plasma/serum and red blood cell levels of vitamin C are tightly controlled, and vitamin C levels can differ up to 100-fold between plasma and various tissues.

    “Several authors recommend using other blood and tissue markers of vitamin C to predict clinical outcomes, as plasma/serum and red blood cell levels of vitamin C are tightly controlled, and vitamin C levels can differ up to 100-fold between plasma and various tissues [16,27,42,43].”

    From Enhanced Vitamin C Delivery: A Systematic Literature Review Assessing the Efficacy and Safety of Alternative Supplement Forms in Healthy Adults (2025) · cites this paper as [16]

    The Discussion states that plasma vitamin C concentrations are tightly regulated. The Background says leukocytes can maintain concentrations several times higher than plasma, but the paper does not establish tight regulation in red blood cells or an up-to-100-fold difference between plasma and tissues (pages unavailable). (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • At the 1000 mg dose, the tested vitamin C interventions were significantly different from placebo regarding both plasma and leukocyte vitamin C concentrations.

    “At the 1000 mg dose, the tested vitamin C interventions were significantly different from placebo regarding both plasma and leukocyte vitamin C concentrations [16,27].”

    From Enhanced Vitamin C Delivery: A Systematic Literature Review Assessing the Efficacy and Safety of Alternative Supplement Forms in Healthy Adults (2025) · cites this paper as [16]

    The Results sections (page unavailable) report that, at the 1000 mg dose, Ester-C differed significantly from placebo in plasma vitamin C changes and in leukocyte percent changes at 8 and 24 hours. They do not report a significant leukocyte difference between ascorbic acid and placebo; no significant within-group leukocyte change was observed with ascorbic acid. Thus the claim is supported for Ester-C, but not for both tested vitamin C interventions. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Non-linear relations were noted between changes in vitamin C concentration in plasma and leukocytes.

    “Non-linear relations were noted between changes in vitamin C concentration in plasma and leukocytes [16,27].”

    From Enhanced Vitamin C Delivery: A Systematic Literature Review Assessing the Efficacy and Safety of Alternative Supplement Forms in Healthy Adults (2025) · cites this paper as [16]

    The Discussion (page unavailable) reports similar plasma vitamin C changes with Ester-C and ascorbic acid but different leukocyte responses, supporting the idea that changes in the two compartments do not simply track each other. The paper does not explicitly report or test a non-linear relationship between plasma and leukocyte concentration changes. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mitmesser, S. H., Ye, Q., Evans, M., & Combs, M.
Corresponding author
Ye, Qian
Venue
SpringerPlus
Published
2016-07-25
Volume
5
Issue
1
Pages
1161-1161
ISSN
2193-1801 (ISSN-L)
OpenAlex
W2496202077
Cited by
34
References
41
Citations by year
2025: 5 · 2024: 4 · 2023: 8 · 2022: 6 · 2021: 4 · 2020: 5 · 2019: 1 · 2018: 1
FWCI
0.70
Type
journal article
Language
en
Open access
Locations
  • SpringerPlus (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
NBTY
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
  • Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
  • Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
Keywords
vitamin C, bioavailability, plasma vitamin C, tissue retention, immune function, vitamin C supplementation, ascorbyl palmitate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review